Compare AbCellera Biologics Inc (ABCL) vs Suncor Energy Inc. (SU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Suncor Energy Inc. — how do they compare? AbCellera Biologics Inc trades at $7.15 (market cap $2.35B), while Suncor Energy Inc. trades at $58.5 (market cap $66.94B). The key difference: Suncor Energy Inc. is far larger — about 28.5× AbCellera Biologics Inc's market cap, and Suncor Energy Inc. pays a 2.98% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | SU | |
|---|---|---|
Market Cap | $2.35B | $66.94B |
Sector | Health | Energy |
52-Week High | $8.12 | $69.73 |
52-Week Low | $2.78 | $38.17 |
Enterprise Value | $1.99B | $75.07B |
Dividend Yield | — | 2.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
Suncor Energy (SU) trades at $56.66, up 2.92% today, with a bullish technical signal despite mixed moving averages. The stock shows solid fundamentals with a P/E of 14.82, net margin of 11.62%, and consistent dividend payments, including a recent $0.60 distribution. Recent earnings beat expectations in Q3 and Q4 2025, though Q1 2026 missed estimates. Analyst consensus is strongly positive with 74% buy ratings.
Outlook remains favorable due to attractive valuation and strong cash flow, but risks include oil price volatility and operational incidents like the recent Sarnia refinery fire. Earnings growth and disciplined capital allocation are key catalysts for upside, while macroeconomic pressures pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
